ANISH S NANAVATI
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology WALDORF, MD NPI 1154582989
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology MD Celgene Corporation All categories
General Payments — all program years on this page
$2,585.38
- Category: General Payments
- Program years: PY2020–2024
- Record count: 96
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,246.77 across 42 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,246.77 | 42 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Celgene Corporation | $293.17 | 4 |
| Janssen Biotech, Inc. | $192.10 | 8 |
| Medtronic, Inc. | $138.66 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $51.84 | 2 |
| PFIZER INC. | $47.25 | 2 |
| ABBVIE INC. | $45.54 | 2 |
| Incyte Corporation | $40.87 | 2 |
| Astellas Pharma US Inc | $38.56 | 2 |
| EISAI INC. | $36.00 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $34.67 | 1 |
| PharmaEssentia USA Corporation | $32.98 | 1 |
| TAIHO ONCOLOGY, INC. | $29.98 | 2 |
| ADC Therapeutics America, Inc. | $28.60 | 1 |
| TerSera Therapeutics LLC | $28.23 | 1 |
| Stemline Therapeutics Inc. | $27.18 | 1 |
| Gilead Sciences, Inc. | $26.23 | 1 |
| Spectrum Pharmaceuticals Inc. | $23.73 | 1 |
| Pharmacosmos Therapeutics Inc. | $21.76 | 1 |
| Exelixis Inc. | $18.50 | 1 |
| Acerta Pharma LLC | $16.76 | 1 |
| Lilly USA, LLC | $15.69 | 1 |
| Merck Sharp & Dohme Corporation | $15.58 | 1 |
| Coherus Biosciences Inc. | $15.42 | 1 |
| SERVIER PHARMACEUTICALS LLC | $14.02 | 1 |
| Daiichi Sankyo Inc. | $13.45 | 1 |
By program year
Records — PY2024 (42)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.